Bo Wang Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

5/2024	FTO blocks RNA translational activity via the loss of N6-methyladenosine methylation at 5' UTR regulated by RBM5 in cisplatin-resistant NSCLC.
1/2024	Mechanisms of resistance to targeted therapy and immunotherapy in non-small cell lung cancer: promising strategies to overcoming challenges.
9/2023	Long noncoding RNA LGALS8-AS1 promotes angiogenesis and brain metastases in non-small cell lung cancer.
4/2023	Efficacy of anlotinib combined with radioiodine to treat scalp metastasis of papillary thyroid cancer: A case report and review of literature.
4/2023	Diagnostic value of dynamic 18F-FDG PET/CT imaging in non-small cell lung cancer and FDG hypermetabolic lymph nodes.
12/2022	Effects of p450 Polymorphisms on the Clinical Outcomes of Gefitinib Treatment in Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer.
1/2022	Primary resistance to first- and second-generation ALK inhibitors in a non-small cell lung cancer patient with coexisting ALK rearrangement and an ALK F1174L-cis-S1189C de novo mutation: A case report.
1/2022	NLR family CARD domain containing 5 promotes hypoxia-induced cancer progress and carboplatin resistance by activating PI3K/AKT via carcinoembryonic antigen related cell adhesion molecule 1 in non-small cell lung cancer.
12/2021	Effects of dacomitinib on the pharmacokinetics of poziotinib in vivo and in vitro.
12/2020	Survival outcomes and symptomatic central nervous system (CNS) metastasis in EGFR-mutant advanced non-small cell lung cancer without baseline CNS metastasis: Osimertinib vs. first-generation EGFR tyrosine kinase inhibitors.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bo Wang Research Topics

Disease

586	Neoplasms (Cancer) 12/2024 - 02/2003
139	Inflammation (Inflammations) 03/2024 - 03/2006
115	Infections 04/2024 - 10/2006
88	Neoplasm Metastasis (Metastasis) 03/2024 - 09/2002
76	Breast Neoplasms (Breast Cancer) 02/2024 - 09/2002
55	Fibrosis (Cirrhosis) 06/2024 - 04/2008
51	COVID-19 04/2024 - 01/2020
51	Hypoxia (Hypoxemia) 03/2024 - 01/2005
47	Stomach Neoplasms (Stomach Cancer) 02/2024 - 10/2008
44	Carcinogenesis 01/2024 - 03/2006
41	Pain (Aches) 03/2024 - 09/2009
39	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 07/2008
36	Carcinoma (Carcinomatosis) 01/2024 - 05/2005
35	Lung Neoplasms (Lung Cancer) 05/2024 - 06/2007
34	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 07/2003
33	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 06/2013
33	Hemorrhage 09/2023 - 01/2008
32	Glioma (Gliomas) 01/2024 - 01/2008
31	Wounds and Injuries (Trauma) 02/2024 - 01/2007
31	Lymphatic Metastasis 01/2024 - 09/2002
30	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 02/2006
30	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2023 - 02/2006
29	Atherosclerosis 01/2023 - 01/2008
27	Body Weight (Weight, Body) 04/2024 - 01/2005
26	Obesity 04/2024 - 03/2007
25	Prostatic Neoplasms (Prostate Cancer) 06/2023 - 12/2008
22	Type 2 Diabetes Mellitus (MODY) 03/2024 - 02/2016
22	Heart Failure 02/2024 - 04/2004
22	Stroke (Strokes) 01/2024 - 10/2007
22	Necrosis 10/2023 - 09/2006
22	Myocardial Infarction 03/2023 - 01/2013
22	Pancreatic Neoplasms (Pancreatic Cancer) 12/2022 - 12/2003
20	Osteosarcoma (Osteogenic Sarcoma) 03/2024 - 08/2012
20	Acute Kidney Injury (Acute Renal Failure) 09/2023 - 04/2013
19	Insulin Resistance 04/2024 - 04/2006
19	Hypertension (High Blood Pressure) 04/2024 - 10/2007
19	Urinary Bladder Neoplasms (Bladder Cancer) 04/2024 - 02/2015
19	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 03/2016
18	Critical Illness (Critically Ill) 01/2024 - 02/2007
17	Neuroinflammatory Diseases 01/2024 - 10/2012
17	Atherosclerotic Plaque (Atheroma) 01/2023 - 01/2009
16	Adenocarcinoma 12/2023 - 02/2009
16	Malaria 09/2020 - 11/2011
15	Adenocarcinoma of Lung 03/2024 - 11/2012
15	Osteoporosis 02/2024 - 12/2009
15	Glioblastoma (Glioblastoma Multiforme) 01/2024 - 04/2011
15	Pneumonia (Pneumonitis) 08/2023 - 01/2015
14	Rheumatoid Arthritis 03/2024 - 04/2012
14	Alzheimer Disease (Alzheimer's Disease) 12/2023 - 10/2012

Drug/Important Bio-Agent (IBA)

202	Proteins (Proteins, Gene)FDA Link 04/2024 - 09/2002
132	Biomarkers (Surrogate Marker)IBA 06/2024 - 10/2006
87	MicroRNAs (MicroRNA)IBA 02/2024 - 07/2008
60	Messenger RNA (mRNA)IBA 03/2024 - 01/2005
51	RNA (Ribonucleic Acid)IBA 03/2024 - 09/2013
50	CytokinesIBA 01/2024 - 04/2007
46	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 08/2008
42	Long Noncoding RNAIBA 09/2023 - 01/2015
34	Therapeutic UsesIBA 03/2024 - 09/2006
34	EnzymesIBA 02/2024 - 02/2004
32	LipidsIBA 04/2024 - 01/2008
31	DNA (Deoxyribonucleic Acid)IBA 05/2024 - 07/2008
31	Transcription Factors (Transcription Factor)IBA 03/2024 - 01/2008
30	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2024 - 07/2003
30	AntigensIBA 03/2024 - 01/2008
30	Small Interfering RNA (siRNA)IBA 11/2023 - 09/2008
26	CollagenIBA 06/2024 - 04/2008
26	VaccinesIBA 04/2024 - 07/2011
26	Oxygen (Dioxygen)IBA 03/2024 - 01/2005
25	AcidsIBA 05/2024 - 05/2009
24	1-phenyl-3,3-dimethyltriazene (PDT)IBA 05/2024 - 09/2006
23	Peptides (Polypeptides)IBA 04/2024 - 10/2009
22	AntioxidantsIBA 03/2024 - 02/2004
21	Insulin (Novolin)FDA Link 01/2024 - 02/2006
21	Interleukin-6 (Interleukin 6)IBA 08/2023 - 09/2012
20	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 09/2007
20	Circular RNAIBA 12/2023 - 01/2017
19	Antiviral Agents (Antivirals)IBA 05/2024 - 01/2005
19	Indicators and Reagents (Reagents)IBA 05/2024 - 04/2011
19	AntibodiesIBA 03/2024 - 12/2011
19	Sirtuin 1IBA 11/2023 - 03/2013
17	IronIBA 05/2024 - 01/2010
17	Immune Checkpoint InhibitorsIBA 04/2024 - 02/2019
17	Phosphotransferases (Kinase)IBA 01/2024 - 11/2008
17	Lysine (L-Lysine)FDA Link 01/2024 - 02/2015
17	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023 - 04/2006
16	Histones (Histone)IBA 09/2023 - 02/2014
16	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 11/2008
14	LipopolysaccharidesIBA 03/2024 - 08/2005
14	InflammasomesIBA 03/2024 - 01/2016
14	LigandsIBA 01/2024 - 08/2015

Therapy/Procedure

283	Therapeutics 05/2024 - 02/2003
72	Drug Therapy (Chemotherapy) 05/2024 - 10/2007
51	Immunotherapy 04/2024 - 01/2008
28	Transplantation 05/2024 - 11/2004
26	Photochemotherapy (Photodynamic Therapy) 05/2024 - 09/2006
22	Radiotherapy 05/2024 - 06/2005
22	Aftercare (After-Treatment) 03/2024 - 09/2006
18	Lasers (Laser) 02/2024 - 09/2006
17	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2024 - 07/2007
16	Liver Transplantation 11/2023 - 11/2004